Magdalena B. Wozniak, Raquel Villuendas, James R. Bischoff, Carmen Blanco Aparicio, Juan F. Martínez Leal, Paloma de La Cueva, Ma Elena Rodriguez, Beatriz Herreros, Daniel Martin-Perez, Maria I. Longo, Marta Herrera, Miguel Á. Piris, Pablo L Ortiz-Romero. Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma. haematol [Internet]. 2010Apr.8 [cited 2024Nov.22];95(4):613-21. Available from: https://haematologica.org/article/view/5558